Effect of Ventilation Mode in the Pupillary Light Reflex: A Crossover Study
EYE-BREATH
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of this clinical trial is to explore whether different modes of mechanical ventilation affect pupillary constriction velocities in critically ill patients without brain injury. The study aims to determine whether the type of mechanical ventilation (volume control, pressure control, or pressure-regulated volume control) influences the maximum and mean constriction velocity measured by automated pupillometry. The trial also investigates whether changes in pupil dynamics reflect subtle alterations in brainstem-autonomic interaction induced by ventilation mode. The comparison involves volume control, pressure control, and pressure-regulated volume control in a randomized crossover design to assess whether ventilation mode has a measurable effect on pupil response. Eligible participants will be intubated ICU patients receiving assist control ventilation who are not yet ready for spontaneous breathing trials. Serial pupillometry measurements will be conducted while participants are ventilated with each mode for at least 15 minutes. Sedation and lighting conditions will remain consistent throughout the protocol. Participants with acute or chronic neurologic conditions or ventilator dyssynchrony will be excluded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2025
CompletedStudy Start
First participant enrolled
July 15, 2025
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
ExpectedJuly 24, 2025
July 1, 2025
2 months
July 5, 2025
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum Pupillary Constriction Velocity
Change in maximum pupillary constriction velocity (mm/s) in response to standardized light stimulus, as measured by the NPi-200 pupillometer, under three modes of mechanical ventilation: Volume Control (VC), Pressure Control (PC), and Pressure-Regulated Volume Control (PRVC).
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
Secondary Outcomes (6)
Neurological Pupil Index (NPi)
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
Constriction Latency
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
Dilation Velocity
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
Maximum Pupil Diameter
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
Minimum Pupil Diameter
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
- +1 more secondary outcomes
Other Outcomes (11)
Exploratory Outcome Measure - Heart Rate Variability (HRV)
Time interval between 15-30 minutes after the initiation of each ventilation mode (VC, PC, PRVC)
Systolic Blood Pressure (mmHg)
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
Diastolic Blood Pressure (mmHg)
At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).
- +8 more other outcomes
Study Arms (6)
Sequence A: VC → PC → PRVC
EXPERIMENTALParticipants receive mechanical ventilation in the following sequence: Volume Control (VC), followed by Pressure Control (PC), then Pressure-Regulated Volume Control (PRVC). Pupillometry is performed after each mode following a 15-minute stabilization period.
Sequence B: VC → PRVC → PC
OTHERParticipants receive mechanical ventilation in the following sequence: Volume Control (VC), followed by Pressure-Regulated Volume Control (PRVC), then Pressure Control (PC). Pupillometry is performed after each mode following a 15-minute stabilization period.
Sequence C: PC → VC → PRVC
OTHERParticipants receive mechanical ventilation in the following sequence: Pressure Control (PC), followed by Volume Control (VC), then Pressure-Regulated Volume Control (PRVC). Pupillometry is performed after each mode following a 15-minute stabilization period.
Sequence D: PC → PRVC → VC
OTHERParticipants receive mechanical ventilation in the following sequence: Pressure Control (PC), followed by Pressure-Regulated Volume Control (PRVC), then Volume Control (VC). Pupillometry is performed after each mode following a 15-minute stabilization period.
Sequence E: PRVC → VC → PC
OTHERParticipants receive mechanical ventilation in the following sequence: Pressure-Regulated Volume Control (PRVC), followed by Volume Control (VC), then Pressure Control (PC). Pupillometry is performed after each mode following a 15-minute stabilization period.
Sequence F: PRVC → PC → VC
OTHERParticipants receive mechanical ventilation in the following sequence: Pressure-Regulated Volume Control (PRVC), followed by Pressure Control (PC), then Volume Control (VC). Pupillometry is performed after each mode following a 15-minute stabilization period.
Interventions
Standard mode of mechanical ventilation delivering a preset tidal volume. Commonly used in ICU patients requiring controlled ventilation.
Pressure-targeted ventilation mode that delivers breaths at a fixed pressure. Commonly used in critically ill patients.
Hybrid ventilation mode that automatically adjusts inspiratory pressure to achieve a preset tidal volume.
Eligibility Criteria
You may qualify if:
- Adult patients (≥18 years old)
- Receiving positive-pressure mechanical ventilation
- Under light or no sedation (e.g., RASS score between -2 and 0)
- Clinically assessed by the treating physician as not yet ready for weaning from mechanical ventilation
- Hemodynamically stable at the time of measurement
- Presence of an arterial catheter in place for blood gas analysis
You may not qualify if:
- Acute or chronic neurological disease affecting brainstem function or pupillary responses
- Dyssynchrony with the ventilator or need for high ventilatory support adjustments
- Facial injuries, edema, or conditions precluding accurate pupillometry
- Use of neuromuscular blocking agents within the prior 6 hours
- Severe metabolic or acid-base imbalances that may influence autonomic regulation
- Concurrent participation in another interventional study that could affect neurological or autonomic outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
!st ICU dpt., Evangelismos Hospital
Athens, 10676, Greece
Related Publications (6)
Sibbald B, Roberts C. Understanding controlled trials. Crossover trials. BMJ. 1998 Jun 6;316(7146):1719. doi: 10.1136/bmj.316.7146.1719. No abstract available.
PMID: 9614025BACKGROUNDWorld Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053. No abstract available.
PMID: 24141714BACKGROUNDMuppidi S, Adams-Huet B, Tajzoy E, Scribner M, Blazek P, Spaeth EB, Frohman E, Davis S, Vernino S. Dynamic pupillometry as an autonomic testing tool. Clin Auton Res. 2013 Dec;23(6):297-303. doi: 10.1007/s10286-013-0209-7. Epub 2013 Jul 24.
PMID: 23880969BACKGROUNDBassi TG, Rohrs EC, Fernandez KC, Ornowska M, Nicholas M, Gani M, Evans D, Reynolds SC. Transvenous Diaphragm Neurostimulation Mitigates Ventilation-associated Brain Injury. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1391-1402. doi: 10.1164/rccm.202101-0076OC.
PMID: 34491883BACKGROUNDCinnella G, Conti G, Lofaso F, Lorino H, Harf A, Lemaire F, Brochard L. Effects of assisted ventilation on the work of breathing: volume-controlled versus pressure-controlled ventilation. Am J Respir Crit Care Med. 1996 Mar;153(3):1025-33. doi: 10.1164/ajrccm.153.3.8630541.
PMID: 8630541BACKGROUNDWalter K. Mechanical Ventilation. JAMA. 2021 Oct 12;326(14):1452. doi: 10.1001/jama.2021.13084. No abstract available.
PMID: 34636861BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charikleia S Vrettou, MD, PhD
!st ICU dpt., Evangelismos General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will be masked to the ventilation mode sequence applied during each pupillometry measurement. Pupillometry data will be anonymized and coded prior to statistical analysis to prevent bias in outcome evaluation.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 5, 2025
First Posted
July 24, 2025
Study Start
July 15, 2025
Primary Completion
September 15, 2025
Study Completion (Estimated)
September 30, 2026
Last Updated
July 24, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Beginning 6 months after publication of the primary manuscript and continuing for 3 years.
- Access Criteria
- Access will be granted to qualified researchers for scientifically sound proposals. Requesters will need to submit a brief proposal outlining the purpose and methods of the secondary analysis.
De-identified individual participant data (IPD) related to primary and secondary outcome measures will be made available to other researchers upon reasonable request, after publication of the main study results.